Articles by Kevin Gopal - Pharmaceutical Executive

ADVERTISEMENT

Articles by Kevin Gopal

Kevin Gopal

International Correspondent

Kevin Gopal is Pharmaceutical Executive's international correspondent, covering pharma and regulatory issues around the word. He is also a political columnist for North West Business Insider, one of the UK's leading regional business magazines. He started his career as a journalist at SiYu, the UK's Chinese community magazine, before joining the PE staff.

Articles
South Africa Continues to Resist Anti-AIDs Efforts
April 1, 2002

Capetown-In March, ruling on a case initiated by the Treatment Action Campaign, Save Our Babies, and the Children's Rights Centre, Judge Chris Botha ordered the South African government to provide the anti-retroviral nevirapine to all HIV-positive pregnant women.

Depressing News About Antidepressants
April 1, 2002

London, UK - According to the magazine Health Which?, patients fail to receive full information about the efficacy and safety of antidepressants, including the risks of withdrawal and suicidal behavior.

GSK Faces Bribe Charges, Changing of the Guard
April 1, 2002

GSK Faces Bribe Charges, Changing of the Guard

Call for Aid to Afghanistan
April 1, 2002

Brussels, Belgium-Tackling communicable diseases such as malaria and tuberculosis and making pregnancy and childbirth safer are priorities for the restructured Afghan health ministry, according to World Health Organization officials.

MSF Exposes Malaria Myths
April 1, 2002

A new report by Médecins Sans Frontières (MSF) scotches the myth that the most effective forms of malaria treatment are too expensive for East African countries.

The Children's Hour
April 1, 2002

More than a fifth of the people in the European Union are age 16 or under, yet at least half of the medicines in use there have not been tested on children. As a result, the region suffers from a lack of information about the safety and efficacy of pediatric medicines and of off-label pediatric use that medical experts say could cause adverse effects and even death.

Drug Promotion to Docs on the Defensive
April 1, 2002

Canberra, Australia-The Australian Pharmaceutical Manufacturers' Association has denounced calls from the country's media and some of its doctors to drastically curtail drug promotion. APMA chief executive Alan Evans says any such move would severely affect the healthcare of millions of people in Australia and could even result in premature death.

Pfizer Boosts Battle Against Blindness
March 1, 2002

Pfizer's $20 million donation of the long-acting antibiotic Zithromax (azithromycin), which is effective against trachoma with a single annual oral dose, has propelled the worldwide effort against the disease into its second phase

Global Programs Struggle
March 1, 2002

t a January meeting in Geneva, the Global Fund to fight AIDS, Tuberculosis, and Malaria (GFATM)-set up last year by an alliance of private donors, nongovernmental organizations (NGOs), foundations, national governments, and intergovernmental organizations-elected its directors, announced its funding criteria, and approved its first call for funding proposals.

ADVERTISEMENT

Click here